Tom Yarbrough, DVM
CoFounder, CEO and Director
Tom is a world-renowned equine orthopedic surgeon with 30 years experience treating performance horses and chief surgeon positions at Nor Cal Surgical, Dubai Equine Hospital and Cornell Ruffian Equine at Belmont Park. He established a testing base for Tesio-102 in horses within his global network of equine trainers, to facilitate Tesio’s choice of starting doses for planned toxicology and first in human studies.
Dominik Haudenschild, PhD
CoFounder, CSO and Director
Dominik is a Professor in the Department of Orthopaedic Surgery at UC Davis School of Medicine. His training is in the biochemistry and molecular biology of orthopaedic tissues, and his current research focuses on how early injury responses affect the inflammatory response, fibrotic response, and overall disease trajectory of osteoarthritis
Jasper Yik, PhD
CoFounder, Sr. Scientist and Director
Jasper is a Molecular Biologist at UC Davis with over 18 years of advanced research experience in the regulation of gene expression that globally affects acute injury responses, inflammation, and osteoarthritis pathogenesis.
Art Tiption, phd
Consulting Head of Manufacturing
Art, a chemist and polymer scientist has extensive drug delivery commercialization experience. With significant roles at three drug delivery companies; including Founder and CEO, and President of two GMP PL/GA suppliers. Art is a past president and fellow of CRS, and a member of the National Academy of Inventors and the National Academy of Engineers.